AP-PA-02

N/A

Report date: 2024/11/07 14:31:16

Base Information

Drug NameAP-PA-02
Drug Alias NameAP-PA02
ClassificationBiologics > Bacteriophages
Mechanisms of ActionCell death stimulants
TargetsUpdating
Therapy Area/IndicationsLung DiseasesBronchiectasisCystic Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArmata Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArmata Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLung DiseasesBronchiectasisCystic Fibrosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A